Creative Details

Quality Score: 6/10

The advertisement promotes Bimzelx®, a prescription medicine approved for treating moderate-to-severe hidradenitis suppurativa, highlighting its unique status as a first-of-its-kind treatment.

Creative Information

CID:4b4218e0-1e39-477d-a8fa-d4a689a13348
CRID:25_wv3yplff
Domain:ucb.com
Seat:TTD
Size:300x250
Bid:$3.07
Timestamp:11/26/2025, 4:32:34 PM
Declared IAB Categories:

    Analysis

    5 succeeded(100% complete)
    TaskStatusLast UpdatedDurationActions
    ad_analysissuccess11/26/2025, 4:33:36 PM5.86s
    adomain_analysissuccess11/26/2025, 4:44:07 PM4.17s
    adomain_capturesuccess11/26/2025, 4:44:02 PM0.19s
    ad_rendersuccess11/26/2025, 4:33:30 PM24.03s
    brand_mappingsuccess11/26/2025, 4:32:39 PM1.03s

    Analysis Results

    Ad Format: banner

    Brands: UCB

    Sensitive:Pharmaceutical Products
    Quality:Adomain not match landing page domain
    Size:300x250
    Data Transferred:1435.64 KB
    Render Time:8.48 Seconds
    Creative Inferred IAB Categories:
    • Health & Fitness (IAB7)
    Creative Inferred IAB Ad Products:
    • Health and Medical Services (1378)
    • Pharmaceuticals (1473)
    Domain Inferred IAB Categories:
    • Business (IAB3)
    • Health & Fitness (IAB7)
    • Science (IAB15)
    Domain Inferred IAB Ad Products:
    • Medical and Biotechnology (1043)
    • Health and Medical Services (1378)
    • Pharmaceuticals (1473)
    Landing Page:
    Total Ad Size:1454.85 KB
    Requests Made:
    URLSize (KB)
    https://cdn.doubleverify.com/dvbm.js529.96
    https://pagead2.googlesyndication.com/pagead/managed/js/activeview/current/ufs_web_display.js222.95
    https://s0.2mdn.net/879366/express_html_inpage_rendering_lib_200_287.js116.69
    https://ad.doubleclick.net/ddm/adj/N6172.3958509PMPRECISIONPHMPMEDI/B32818688.430168682;dc_ver=106.314;dc_eid=40004000;sz=300x250;u_sd=1;gdpr=0;nel=1;dc_adk=2027040026;ord=8sd22v;click=https%3A%2F%2Finsight.adsrvr.org%2Ftrack%2Fclk%3Fimp%3D709e14ee-bd83-43a8-af51-437583cf4a04%26ag%3D3a7g50t%26sfe%3D1b5dcd1e%26sig%3D1MN4olS85MlIIRtq2LdtnoMmXdyNq75hsRGw4bfs91Q.%26crid%3Dwv3yplff%26cf%3D9635432%26fq%3D0%26t%3D1%26td_s%3Dsugarspunrun.com%26rcats%3D2ic%2C7gr%2Chhr%2Chmy%2C26o%2Czm4%26mste%3Dsugarspunrun.com%26mfld%3D2%26mssi%3D%26mfsi%3D%26sv%3Dkargo%26uhow%3D66%26agsa%3D%26wp%3D3.0721896%26rgz%3D38016%26dt%3DPC%26osf%3DWindows%26os%3DWindows10%26br%3DChrome%26svpid%3D8482%26rlangs%3Den%26mlang%3D%26did%3D%26rcxt%3DOther%26tmpc%3D15.890000000000043%26vrtd%3D%26osi%3D%26osv%3D%26daid%3D%26dnr%3D0%26vpb%3D%26crrelr%3D%26npt%3D2%26cc%3D2~KLUv_WMdqREMIwQNGADTYn9ROUG4XFtUbk1Uji0qx2WK6uVywxKjR4y0rhkHHASpcyOQDt8RLKpLCqqKiLnq3oqI6fteGCVhlFhRTeV4_OA4kQaBGlxwnRKw2gtUIA9X1E-uEj5Xxani-93nYWRkR_q51X1iMf5F_6jcsmTVyEUjI3bRZDcZ2pA31lVGBhzLkXeVN4a1Bq_W63DHw9Fg3ondEZG78Ez2bY9gQP-uwj40sCEXMZeGXdG6-DM6e-U-za5PM27PiEbVpWRUZJnSKiZz7_8J3JdzXSTaXX612Cw65-yVKabjRY3aH9mV2UTGW_q3PPsaYn9LHpEqFEMDns1BahcXVerFJAsD23k_uUl2J4G-Hi3G3fKUZl6-3m_30Tr2uLWxVW32-oN9-KtMKpV1L7vOk9pr124WJEqX1KMfI8nCgjbXVHcnoWZce39mja9apw5avM3G8J_Is5aVPXm9r6HYTf0RlWFgT9iKEA80l9j6CMYcm_a82Pc4h-u_3-25p3s7z_2yQF8SXfVv7NxJ4kUHHjxI9jASM4QT2xh1twPLIVybtRr7XNmHHxr-8fRI4sYFJzxWDBLw7p-f-7nW-TJ963p-j-m9zrXSsHXT_t8p3c5vZijyaoDikBShFa6Ttz5X8aa45Ki49pBT3t5aGBVSIhIg2XNv27p5t_9chmutDg2mZDGXNA1DA0n8gIUydxFPqxCRO_rc9T0_iM0nmvrfojLUkqNwHEL1BTtkGk80FSRuDmBSgbqjBTjFM3M1J9STH49cep0DYp2VXeU-fH9VyBDVq6b_HJwbt98A0RTPsXkvfvUzBShx8Ij0JGSyd7Fh9O9GiLr2ZBMH043YaeslWWy74rlIdWM3YAfOTqU918M1c0jxYm9I69sAUsKpOttNTFvre6yjZwokHL6BhxnvKa-2KVG_-H5HMSGI5FOV1VnfmF2_pau4bOIvrUyRtt_Sjc30mYpQ6MMKJKdVCz2Xz6GAzmWx4RrLZ2oiHmhXPTt0W9w1AAzlscdUeIwsDQ-pbK70R3cy2AsB%26dur%3D1~KLUv_WMFoCgkpAAVAwDjhA8XmLqhxieCC6iw3zvmrncZ2wq1jRpK-ynsMkZIua-_X8mSSi8jJadqY6wjMWmigmIPJQJ5A-CIXJ3TJZpprAn8LodWz_I5g6aKpz2K5N0VgySFCY-hjjvj4ZynDQlkAw..%26durs%3DO3azaB%26bdc%3D131%26uidd%3DmSThKEr7UIRCBmXXtBKf8VY7Ln-lxu1tZdbJYng7-qJ6GTWQ%26idl%3DXY3007N1eNripKGYbOuxg956Pa2ppXR0e0Euwxsv6yNva4DbE%26testid%3Diavc1%2520%26car%3D32%26fpa%3D343%26pcm%3D3%26ict%3DCellularNetwork4G%26said%3D5e996d40-4578-4a1d-b66a-e7b936b491c7%26auct%3D1%26us_privacy%3D1YNY%26tail%3D1%26r%3D;uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.;dc_rfl=1,https%3A%2F%2Fecho-server.dangoldin.workers.dev%2F$0;xdt=0;crlt=K8.5LGkcTR;gcsr=m;stc=1;chaa=1;sttr=82;prcl=s108.00
    https://cdnjs.cloudflare.com/ajax/libs/gsap/3.12.3/gsap.min.js70.49
    https://www.googletagservices.com/dcm/impl_v106.js68.78
    https://ep1.adtrafficquality.google/bg/-wXAbvSYfhK0SAyKT13WM5MC55VpScGMR1HCkTOFAzM.js53.82
    https://ep2.adtrafficquality.google/sodar/VFc2VJAc.js42.74
    https://choices.truste.com/ca?pid=tradedesk01&aid=tradedesk01&cid=82ze1st_3a7g50t_wv3yplff&c=tradedesk01cont1&js=pmw0&w=300&h=250&sid=0&dsarequired=&dsabehalf=&dsapaid=&dsaparams=21.19
    https://choices.trustarc.com/get?name=pmw2.js19.05

    Advertiser Domain

    Advertiser Domain

    Ad Preview

    Landing Page

    Landing Page

    Creatives

    Creative Screenshot 1Creative Screenshot 2Creative Screenshot 3